切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2023, Vol. 17 ›› Issue (01) : 48 -54. doi: 10.3877/cma.j.issn.1674-1358.2023.01.008

论著

慢性丙型肝炎患者干眼临床特征
王胜男1, 孙挥宇1,(), 接英2, 谢雯3, 毛菲菲1, 李丹1, 鲁丹1, 刘夕瑶1   
  1. 1. 100015 北京,首都医科大学附属北京地坛医院眼科 感染病科国家临床重点专科
    2. 100730 北京,首都医科大学附属北京同仁医院北京同仁眼科中心北京市眼科研究所北京市眼视光与视觉科学重点实验室
    3. 100015 北京,首都医科大学附属北京地坛医院肝病中心 感染病科国家临床重点专科
  • 收稿日期:2022-04-27 出版日期:2023-02-15
  • 通信作者: 孙挥宇
  • 基金资助:
    北京市医院管理中心项目(No. DFL20191802); REAL-C:源自亚洲肝病联合会的真实世界的HCV病例(No. 733564)

Clinical characteristics of dry eye in patients with chronic hepatitis C

Shengnan Wang1, Huiyu Sun1,(), Ying Jie2, Wen Xie3, Feifei Mao1, Dan Li1, Dan Lu1, Xiyao Liu1   

  1. 1. Department of Ophthalmology, National Clinical Key Department of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
    2. Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100730, China
    3. Center of Liver Diseases, National Clinical Key Department of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
  • Received:2022-04-27 Published:2023-02-15
  • Corresponding author: Huiyu Sun
引用本文:

王胜男, 孙挥宇, 接英, 谢雯, 毛菲菲, 李丹, 鲁丹, 刘夕瑶. 慢性丙型肝炎患者干眼临床特征[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(01): 48-54.

Shengnan Wang, Huiyu Sun, Ying Jie, Wen Xie, Feifei Mao, Dan Li, Dan Lu, Xiyao Liu. Clinical characteristics of dry eye in patients with chronic hepatitis C[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(01): 48-54.

目的

分析慢性丙型肝炎(CHC)患者干眼的临床特征。

方法

收集2021年2月至2022年1月于首都医科大学附属北京地坛医院肝病科确诊并于眼科筛查的CHC患者共69例(138只眼),年龄23~75岁,平均(45.39 ± 12.88)岁。收集患者病史、血小板计数(PLT)、丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)检测值,并计算AST/PLT比值指数(APRI)。对患者行干眼相关检查,即国际标准眼表疾病指数(OSDI)干眼问卷调查、泪液分泌(Schirmer Ⅰ)试验及干眼眼表分析仪检查[(平均非接触式泪膜破裂时间(NIBUTav)和泪河高度测定(TMH)]。患者OSDI得分0~12分为无症状组(36例)和OSDI≥ 13分为有症状组(33例)。依据数据类型采用独立样本t检验、秩合检验及Pearson χ2检验进行统计学处理。

结果

无症状组患者Schirmer Ⅰ为12.5(8.25,17.75)mm/5 min,NIBUTav为12.1(6.35,20.65)s,TMH为0.26(0.19,0.34)mm;有症状组患者Schirmer Ⅰ为11(6,19.25)mm/5 min,NIBUTav为7.95(4.78,13.32)s,TMH为0.24(0.20,0.28)mm。27例患者诊断为干眼,以NIBUT结果异常为主要表现,两组患者NIBUT差异有统计学意义(Z = -3.77、P < 0.001),Schirmer Ⅰ差异无统计学意义(Z =-1.15、P = 0.25),TMH差异无统计学意义(Z =-0.96、P = 0.34)。无症状组患者丙型肝炎病毒(HCV)感染病程为7(3.25,12)年,有症状组患者为11(7,16)年,差异有统计学意义(Z =-2.40、P = 0.02)。无症状组和有症状组患者ALT水平分别为79(45.75,128.75)U/L和77.00(42.5,117.5)U/L,差异无统计学意义(Z =-0.14、P = 0.89)。无症状组患者APRI为0.62(0.34,0.88),有症状组患者为0.78(0.61,1.03),差异有统计学意义(Z =-0.20、P = 0.04)。

结论

CHC患者干眼的发病率较高,该类患者应定期进行干眼相关检查,以改善患者的眼表状态。

Objective

To investigate the prevalence of dry eye in patients with chronic hepatitis C (CHC).

Methods

Total of 69 patients (138 eyes) with CHC, who were 23 to 75 years old, with the average of (45.39 ± 12.88) years old, diagnosed in Department of Hepatology of Beijing Ditan Hospital, Capital Medical University from February 2021 to January 2022 were collected. Medical history, levels of platelet count (PLT), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) of the patients were collected and the AST/PLT ratio index (APRI) was calculated. All patients received the international standard ocular surface disease index (OSDI) dry eye questionnaire, and the observation indexes included Schirmer Ⅰ test, noninvasive breakup time average (NIBUTav), tear meniscus height (TMH). According to the OSDI score, patients with 0-12 score were divided into asymptomatic group (36 cases), and with the score ≥ 13 were considered as symptomatic group (33 cases). Statistical treatment was performed by independent sample t-test, rank combination test and Pearson χ2 test according data type.

Results

Schirmer Ⅰ of patients in asymptomatic group was 12.5 (8.25, 17.75) mm/5 min, NIBUTav was 12.1 (6.35, 20.65) s, TMH was 0.26 (0.19, 0.34) mm; For patients in symptomatic group, Schirmer Ⅰwas 11 (6, 19.25) mm/5 min, NIBUTav was 7.95 (4.78, 13.32) s, TMH was 0.24 (0.20, 0.28) mm. Total of 27 cases were diagnosed as dry eyes, with abnormal results of NIBUT as the main manifestation. There was significant difference in NIBUT between the two groups (Z = -3.77, P < 0.01). But there were no significant difference in Schirmer Ⅰ (Z =-1.15, P = 0.25) and TMH (Z =-0.96, P = 0.34). The course of hepatitis C virus (HCV) infection was 7 (3.25, 12) years in asymptomatic group and 11 (7, 16) years in symptomatic group, with significant difference (Z =-2.40, P = 0.02). ALT levels of patients in asymptomatic group and symptomatic groups were 79 (45.75, 128.75) U/L and 77.00 (42.5, 117.5) U/L, respectively, with significant difference (Z =-0.14, P = 0.89). APRI of patients in asymptomatic group and symptomatic groups were 0.62 (0.34, 0.88) and 0.78 (0.61, 1.03), with significant difference (Z = -0.20, P = 0.04).

Conclusions

The incidence rate of dry eye is high in CHC patients. CHC patients should be regularly examined for dry eye to improve their ocular surface status.

表1 两组慢性丙型病毒性肝炎患者的基本资料
表2 两组患者丙型病毒性肝炎病程及相关指标[M(P25,P75)]
表3 无症状组和有症状组患者干眼诊断
表4 无症状组和有症状组患者干眼指标[M(P25,P75)]
[1]
亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识:定义和分类(2020年)[J]. 中华眼科杂志,2020,56(6):418-422.
[2]
中华预防医学会医院感染控制分会, 中华医学会感染病学分会, 中华预防医学会感染性疾病防控分会, 等. 中国丙型病毒性肝炎医院感染防控指南(2021年版)[J]. 中国感染控制杂志,2021,20(6):487-493.
[3]
Gomes RL, Marques JC, Albers MB, et al. Ocular surface and hepatitis C[J]. Arq Bras Oftalmol,2011,74(2):97-101.
[4]
Cacoub P, Renous C, Rosenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study of 321 patients[J]. Medicine,2000,79(6):47-56.
[5]
斯崇文, 贾辅衷主编. 感染病学[M]. 北京: 人民卫生出版社,2004:309.
[6]
中华医学会肝病学分会, 中华医学会感染病学分会. 丙型肝炎防治指南(2019年版)[J]. 实用肝脏病杂志,2020,23(1):S33-S52.
[7]
Nemeth O, Langenbucher A, Eppig T, et al. Ocular surface disease index and ocular thermography in keratoconus patients[J]. J Ophthalmol,2020,13(56):157-183.
[8]
Yazdani M, Elgstoen K, Rootwelt H, et al. Tear metabolomics in dry eye disease: A review[J]. Int J Mol Sci,2019,20(15):239-255.
[9]
亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识:检查和诊断(2020年)[J]. 中华眼科杂志,2020,56(10):741-747.
[10]
Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women[J]. Am J Ophthalmol,2003,136(2):318- 326.
[11]
Kadhar SR, Belair ML, Jun AS, et al. Seleritis and peripheral ulcerative keratitiswith hepatitis C virus-related cryoglobulinemia[J]. Arch Ophthalmol,2007,125(6):852-853.
[12]
Pedro C, Carlos M, Rita G, et al. Peripheral ulcerative keratitis associated with HCV-related cryoglobulinemia[J]. Case Rep Ophthalmol Med, 2017,2017:9461937.
[13]
Abe T, Nakajima A, Matsunaga M, et al. [J]. Br J Ophthalmol,1999,83(6):684-687.
[14]
Fox RI, Stern M, Michelson P. Update in Sjögren syndrome[J]. Curr Opin Rheumatol,2000,12(5):391-398.
[15]
Santis MD, Crotti C, Selmi C. Liver abnormalities in connective tissue diseases[J]. Best Pract Res Clin Gastroenterol,2013,27(4):543-551.
[16]
Karp JK, Akpek EK, Anders RA. Autoimmune hepatitis in patients with primary Sjögren’s syndrome: a series of twohundred and two patients[J]. Int J Clin Exp Pathol,2010,3(6):582-586.
[17]
Wickham LA, Gao J, Toda I, et al. Identification of androgen,estrogen and progesterone receptor mRNAs in the eye[J]. Acta Ophthalmol Scand,2000,78(2):146-153.
[18]
Vehof J, Hysi PG, Hammond CJ. A Metabolome-Wide study of dry eye disease reveals serum androgens as biomarkers[J]. Ophthalmology,2017,124(4):505-511.
[19]
Wong M, Dodd MM, Masiowski P, et al. Tear osmolarity and subjective dry eye symptoms in migraine sufferers[J]. Can J Ophthalmol,2017,52(5):513-518.
[20]
Huang FC, Shih MH, Tseng SH, et al. Tear function changes during interferon and ribavirin treatment in patients with chronic hepatitis C[J]. Cornea,2005,24(5):561-566.
[21]
Jorgensen C, Legouffe MC, Perney P, et al: Sicca syndrome associated with hepatitis C virus infection[J]. Arthritis Rheum,1996,39(7):1166-1171.
[22]
Roca B. Manifestaciones extrahepáticas de la infección por el virus de la hepatitis C[J]. Enferm Infecc Microbiol Clin,2004,22(8):467-470.
[23]
Ramos-Casals M, Loustaud-Ratti V, De Vita S, et al. Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases[J]. Medicine (Baltimore),2005,84(2):81-89.
[24]
Verbaan H, Carlson J, Eriksson S, et al. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren’s syndrome and hepatitis C in Swedish patients[J]. J Intern Med,1999,245(2):127-132.
[25]
Mayo MJ. Extrahepatic manifestations of hepatitis C infection[J]. Am J Med Sci,2003,325(3): 135-148.
[26]
Popov Y, Salomon-Escoto K. Gastrointestinal and hepatic disease in Sjögren syndrome[J]. Rheum Dis Clin North Am, 2018,44(1):143-151.
[27]
中华医学会眼科学分会角膜病学组. 干眼临床诊疗专家共识(2013年)[J]. 中华眼科杂志,2013,49(1):73-75.
[28]
陈超, 郭纯刚, 曹志军, 等. 肝病患者干眼症患病情况分析[J]. 职业与健康,2012,28(22):2839-2840.
[29]
中联肝健康促进中心, 中华医学会肝病学分会, 中华医学会检验医学分会, 等. 中国丙型病毒性肝炎院内筛查管理流程(试行)[J]. 临床肝胆病杂志,2021,37(7):1534-1539.
[30]
Galor A, Feuer W, Lee DJ, et al. Ocular surface parameters in older male veterans[J]. Invest Opthalmol Vis Sci,2013,54(2):1426-1433.
[31]
Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS Ⅱ diagnostic methodology report[J]. Ocular Surface,2017,15(3):539-574.
[32]
Sang X, Li Y, Yang L, et al. Lipid layer thickness and tear meniscus height measurements for the differential diagnosis of evaporative dry eye subtypes[J]. Int J Ophthalmol,2018,11(9):1496-1502.
[33]
Harrison WW, Begley CG, Liu HX, et al. Menisci and fullness of the blink in dry eye[J]. Optom Vis Sei,2008,85(8):706-714.
[34]
陈宏宇, 亢倩, 罗皓, 等. 真实世界中不同ALT、AST水平慢性丙型肝炎患者对直接抗病毒药物治疗的病毒学应答及肝纤维化指标变化情况[J]. 临床肝胆病杂志,2021,37(2):314-317.
[35]
Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J]. Hepatology,2003,38(2):518-526.
[36]
曹振环, 邹梦娜, 陈新月. 丙型肝炎病毒感染至肝硬化的影响因素分析[J/CD]. 中华实验和临床感染病杂志(电子版),2009,3(1):38-43.
[37]
Gumus K, Yurci A, Mirza E, et al. Evaluation of ocular surface damage and dry eye status in chronic hepatitis C at different stages of hepatic fibrosis[J]. Cornea,2009,28(9):997-1002.
[1] 王月丽, 宋砾, 牛宝荣, 陈炎, 张楠, 何怡华. 心脏血管肉瘤的临床及超声心动图特征[J]. 中华医学超声杂志(电子版), 2023, 20(04): 398-403.
[2] 缪黄泰, 李潇颖, 张明, 聂绍平. 急性心肌梗死后心脏破裂患者院内死亡的危险因素分析[J]. 中华危重症医学杂志(电子版), 2023, 16(03): 187-192.
[3] 董晓燕, 赵琪, 唐军, 张莉, 杨晓燕, 李姣. 奥密克戎变异株感染所致新型冠状病毒感染疾病新生儿的临床特征分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 595-603.
[4] 李小娟, 李炜佳, 彭凌燕, 周鹏莹, 李桂娥, 刘相辰. 体检人群中前列腺钙化灶的检出率及临床特征分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 336-338.
[5] 刘麒, 曾弘, 徐子昕, 方超, 黄铭, 郑俊炯, 吴少旭, 钟广正, 林天歆, 黄健, 董文. 乳头状肾细胞癌单中心11年临床诊治与预后分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 351-355.
[6] 孟原竹, 蒋国路, 陈小兵, 蒋莉. 肺结核合并侵袭性肺曲霉感染临床特征及危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 541-543.
[7] 李华娟, 唐英俊, 王赛妮, 徐旺, 林玲, 李羲, 黄华萍. 肺结节临床与CT影像学特征分析及良恶性预测模型构建[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 318-323.
[8] 田井梅, 何俊, 何永琴, 张玉梅, 郑文红, 袁玉霞. 老年慢性阻塞性肺疾病合并髋部骨折围术期31例临床特征分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 418-420.
[9] 李雅丽, 薛敏君, 韩福. 38例肺隐球菌患者CT及临床特征分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 236-238.
[10] 徐冰, 程明斌, 赵国华. CT影像学征象对局灶性肺炎型肺癌与肺部炎性病变的鉴别意义[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 58-60.
[11] 王欣, 孙丹琦, 黄瑾瑜. 高分辨弥散加权成像ADC直方图参数与直肠癌临床特征相关性的回顾性研究[J]. 中华结直肠疾病电子杂志, 2023, 12(02): 132-138.
[12] 白静怡, 黄轩, 张益权, 田颖, 陶勇. 小鼠干眼模型构建及其角膜特征检测的实验研究[J]. 中华眼科医学杂志(电子版), 2023, 13(01): 12-17.
[13] 王红权, 詹杰, 彭春晓, 梅振华, 邹亮. 肠白塞病的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(02): 220-226.
[14] 张碧莹, 路明, 陈静, 苏元波, 李美娇, 沈宁. 发热门诊轻症鹦鹉热衣原体肺炎的早期识别[J]. 中华临床医师杂志(电子版), 2023, 17(01): 33-36.
[15] 苏琪皓, 解利红, 孟宪梅, 王觅柱, 王晶, 张静洁, 汤泊夫, 江振宇. 消化道毛细血管扩张特征及内镜治疗效果观察[J]. 中华胃肠内镜电子杂志, 2023, 10(03): 180-184.
阅读次数
全文


摘要